Hepatology

Two recent studies examined the effects on sustained virologic response rates in patients with genotypes 1-6 hepatitis C virus infection treated with sofosbuvir and velpatasvir.

There are some epidemics of liver disease that are worthy of contemporary notice. One of note is the hepatitis C infection.

A recent study examined the potential of an inexpensive paper-based device for conducting DNA analyses to diagnose various conditions.

A recent report discusses the factors responsible for underestimated rates of hepatitis C virus infection in the United States.

New clinical trials tested the efficacy of a new antiviral drug regimen for the treatment of patients with hepatitis C virus.

New research investigated a possible association between chronic hepatitis C infection and the risk of developing cardiovascular disease.

Researchers evaluated the efficacy of a new hepatitis C drug combination in helping patients to achieve sustained virologic response, in a new Phase 2 study.

A new study assessed the effects of the addition of a third direct-acting antiviral drug to the combination of sofosbuvir and ledipasvir on the duration of treatment and cure rate in patients with hepatitis...